Axillary lymph-node metabolic activity assessment on 18F-FDG-PET/CT in rheumatoid arthritis patients treated with biologic therapies

Objective: Recent studies have provided new insights into the role of lymph nodes (LNs) in rheumatoid arthritis (RA). The aim of this study was to evaluate the metabolic activity of the axillary LNs in relation to that of the upper limb joints and the clinical assessment of disease activity in RA patients treated with biologic therapies. Method: 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) scans were acquired for 64 patients with RA at baseline and after 6 months of biologic therapy, and the patients’ clinical status was evaluated. The maximum standardized uptake value (SUVmax), metabolic active volume, and total lesion glycolysis (TLG) were used to assess glucose metabolism in the LNs and 12 joints. Clinical evaluations included serum markers and the Disease Activity Score based on 28-joint count–erythrocyte sedimentation rate (DAS28-ESR). Results: Changes in the SUVmax and TLG for the axillary LNs correlated significantly with those of the ipsilateral wrist joints. There was a positive correlation between the changes in the three metabolic parameters of the axillary LNs and the changes in disease activity after treatment. After 6 months of biologic therapy, all metabolic parameters for the axillary LNs in patients with a DAS28-ESR < 3.2 were significantly lower than those of patients with a DAS28-ESR ≥ 3.2. Conclusion: A relationship between the glucose metabolism of the axillary LNs and the ipsilateral wrist joints was demonstrated by the 18F-FDG-PET/CT parameters. The metabolic activity and active volume of axillary LNs may reflect the therapeutic response to the biologic treatment of RA.

[1]  Y. Tsushima,et al.  Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: A prospective study , 2017, Modern rheumatology.

[2]  Y. Tsushima,et al.  Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis , 2017, Medicine.

[3]  Y. Tsushima,et al.  Effect of total knee arthroplasty on other joints in patients with rheumatoid arthritis evaluated by 18‐FDG‐PET , 2017, International journal of rheumatic diseases.

[4]  G. Firestein,et al.  Immunopathogenesis of Rheumatoid Arthritis. , 2017, Immunity.

[5]  R. Caporali,et al.  Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors , 2016, Arthritis Research & Therapy.

[6]  Y. Tsushima,et al.  Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score , 2016, Medicine.

[7]  E. Schwarz,et al.  Relationship Between Lymph Node Volume and Pain Following Certolizumab Therapy for Rheumatoid Arthritis Flare: A Pilot Study , 2016, Clinical medicine insights. Arthritis and musculoskeletal disorders.

[8]  M. Biermann,et al.  Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients , 2015, The Journal of Nuclear Medicine.

[9]  Y. Tsushima,et al.  Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT , 2014, BMC Musculoskeletal Disorders.

[10]  R. Caporali,et al.  B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers , 2014, BioMed research international.

[11]  A. Salavati,et al.  FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  S. Basu,et al.  Regional Lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement , 2014, Rheumatology International.

[13]  P. Tak,et al.  The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis , 2013, Annals of the rheumatic diseases.

[14]  S. Basu,et al.  Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. , 2012, World journal of radiology.

[15]  Y. Tsushima,et al.  The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. , 2012, Rheumatology.

[16]  R. Caporali,et al.  Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography. , 2011, Rheumatology.

[17]  E. Schwarz,et al.  Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. , 2011, Arthritis and rheumatism.

[18]  Alaor Barra Sobrinho,et al.  Extra-articular inflammatory sites detected by F-18 FDG PET/CT in a patient with rheumatoid arthritis. , 2010, Clinical nuclear medicine.

[19]  J. Li,et al.  Expanded CD23+/CD21hi B Cells in Inflamed Lymph Nodes Are Associated with the Onset of Inflammatory-Erosive Arthritis in TNF-Transgenic Mice and Are Targets of Anti-CD20 Therapy , 2010, The Journal of Immunology.

[20]  P. V. van Riel,et al.  The Disease Activity Score and the EULAR response criteria , 2009 .

[21]  K. Kubota,et al.  Whole-body FDG-PET/CT on rheumatoid arthritis of large joints , 2009, Annals of nuclear medicine.

[22]  K. Ohtomo,et al.  Inflammatory Cytokines and Hypoxia Contribute to 18F-FDG Uptake by Cells Involved in Pannus Formation in Rheumatoid Arthritis , 2009, Journal of Nuclear Medicine.

[23]  M. O. Papuga,et al.  Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. , 2007, Arthritis and rheumatism.

[24]  C. Beck,et al.  MRI and Quantification of Draining Lymph Node Function in Inflammatory Arthritis , 2007, Annals of the New York Academy of Sciences.

[25]  R. Caporali,et al.  B cells in rheumatoid arthritis. , 2007, Autoimmunity reviews.

[26]  D. W. Seldin,et al.  Axillary Lymph Node Visualization on F-18 FDG PET Body Scans in Patients With Rheumatoid Arthritis , 2007, Clinical nuclear medicine.

[27]  V. Treyer,et al.  F-18 FDG Whole-Body PET for the Assessment of Disease Activity in Patients With Rheumatoid Arthritis , 2006, Clinical nuclear medicine.

[28]  R. Hustinx,et al.  Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Shigehiro Sato,et al.  Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake , 2003, Annals of nuclear medicine.

[30]  A. Akdoğan,et al.  Frequency of Lymphadenopathy in Rheumatoid Arthritis and Systemic Lupus Erythematosus , 2003, The Journal of international medical research.

[31]  C. Berek,et al.  B cells in rheumatoid arthritis , 2000, Arthritis research.

[32]  P. Bacon,et al.  Rheumatoid lymphadenopathy: a morphological and immunohistochemical study. , 1990, Journal of clinical pathology.

[33]  R. Williams,et al.  Immunocytological studies of lymph nodes in rheumatoid arthritis and malignant lymphoma. , 1980, Annals of the rheumatic diseases.

[34]  J. Nosanchuk,et al.  Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study , 1969, Cancer.

[35]  Y. Tsushima,et al.  [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis , 2015, Rheumatology International.

[36]  J. Li,et al.  Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. , 2013, Arthritis and rheumatism.